Sıçan Kuyruğu Kanama Modelleri: Kapsamlı Bir İnceleme

Year 2026, Volume: 6 Issue: 1, 53 - 62, 24.03.2026

Ahmet Midi , Betül Harman

https://doi.org/10.62425/jlasp.1821795

https://izlik.org/JA98TG72CA

Abstract

Amaçlar: Sıçan kuyruğu kanama modelleri, araştırmacılar tarafından potansiyel hemostatik ve antikoagülan ajanların etkinliğini değerlendirmek için sıklıkla tercih edilmektedir. Sık kullanılmalarına rağmen, farklı çalışmalar arasında metodoloji ve terminoloji açısından tutarsızlıklar bulunmaktadır. Hemostatik ve antikoagülan ajanlar kanama kaynaklı ölümleri azaltmada faydalı olduğundan, sıçan kuyruğu kanama modellerinin standardizasyonu araştırmanın güvenilirliği açısından çok önemlidir.
Yöntemler: 2023 yılında, PUBMED veri tabanında "sıçan kuyruğu kanaması" sorgusu kullanılarak hedefli bir araştırma gerçekleştirilmiştir. Özellikle sıçan kuyruğu kanama modelleri kullanan çalışmaları belirlemek için 172 makalenin özetleri ve yöntemleri incelenmiş ve 70 ilgili makale seçilmiştir.
Sonuçlar: Literatür taraması, aynı yöntemi kullanan çalışmalar ile aynı modeli uygulayan ve farklı adlandıran diğer çalışmalar arasında önemli farklılıklar olduğunu ortaya koymuştur. Ayrıca, kullanılan araçlar, kesi derinlikleri ve kanama değerlendirme tekniklerindeki farklılıklar, bu modellerin güvenilirliğini etkileyen tutarsızlıklara katkıda bulunmaktadır.
Sonuçlar: Sıçan kuyruğu kanama modelleri hakkındaki literatürde tutarlılık ve standardizasyon eksikliği bulunmaktadır ve bu durum araştırmanın güvenilirliğini ve tekrarlanabilirliğini etkilemektedir. Birçok çalışmada aynı model için farklı isimler kullanılması, bazı araştırmacıları şaşırtabilir. Dahası, aynı modeli kullanan çalışmalar arasında bile metodoloji farklılıkları mevcuttur. Bu sorunları ele almak için, hemostatik ve antikoagülan ajanların değerlendirilmesinde önemli rol oynayan sıçan kuyruğu kanama modellerinin standardizasyonu gereklidir.

Keywords

Kanama , Kanama Modelleri , Sıçan Kuyruğu Kanama Modelleri , Hemostaz , Antikoagülan İlaçlar , Hemostatik İlaçlar

Ethical Statement

Çalışmamızda insan ve hayvan deneyleri yer almadığından etik kurul onayına gerek duyulmamıştır.

Supporting Institution

Bu çalışma herhangi bir sponsor, fon sağlayıcı veya kurum tarafından desteklenmemiştir.

Rat Tail Bleeding Models: A Comprehensive Review

https://izlik.org/JA98TG72CA

Abstract

Objectives: Rat tail bleeding models are commonly preferred by researchers for evaluating efficacy of potential hemostatic and anticoagulant agents. Although they are used frequently, there are inconsistencies in terms of methodology and terminology among different studies. As hemostatic and anticoagulant agents are useful to decrease deaths from bleeding, standardization of rat tail bleeding models is crucial for reliability of research.
Methods: In 2023, a targeted research was performed in the PUBMED database using the query "rat tail bleeding". The abstracts and methods of 172 articles were examined to identify studies specifically using rat tail bleeding models and 70 relevant articles were selected.
Results: Literature review revealed significant variations between studies using the same method including other studies implementing the same model and naming it differently. Additionally, differences in tools used, incision depths, and bleeding assessment techniques contribute to inconsistencies affecting reliability of these models.
Conclusions: The literature on rat tail bleeding models lacks consistency and standardization, which affects the reliability and reproducibility of research. Many studies use different names for the same model, which can confuse some researchers. Furthermore, there are variations in methodology even among studies using the same model. To address these issues, standardization of rat tail bleeding models is necessary as they are essential for evaluating hemostatic and anticoagulant agents.

Keywords

Bleeding , Bleeding Models , Rat Tail Bleeding Models , Hemostasis , Anticoagulant Agents , Hemostatic Agents

Ethical Statement

Our study did not require ethical board approval because it did not contain human or animal trials.

Supporting Institution

Funding Sources: This study was not supported by any sponsor, funder or Instution.

References

• Abacıoğlu, S., Aydın, K., Büyükcam, F., Kaya, U., Işık, B., & Karakılıç, M. E. (2016). Comparison of the efficiencies of buffers containing ankaferd and chitosan on hemostasis in an experimental rat model with femoral artery bleeding. Turkish Journal of Haematology, 33(1), 48–52. https://doi.org/10.4274/tjh.2014.0029
• Bian, J., Bao, L., Gao, X., Wen, X., Zhang, Q., Huang, J., Xiong, Z., Hong, F. F., Ge, Z., & Cui, W. (2022). Bacteria-engineered porous sponge for hemostasis and vascularization. Journal of Nanobiotechnology, 20(1), 47. https://doi.org/10.1186/s12951-022-01254-7
• Binnetoglu, K., Kumandas, A., Ekici, H., Ozbaykus, A. C., & Tiryaki, M. (2021). Comparison of the algan hemostatic agent with celox in rat femoral artery bleeding model. Medicine Science International Medical Journal, 4(10). 1469-1473. https://doi.org/10.5455/medscience.2021.05.184
• Bubueanu, C., Iuksel, R., & Panteli, M. (2019). Haemostatic activity of butanolic extracts of Lamium album and Lamium purpureum aerial parts. Acta Pharmaceutica, 69(3), 443–449. https://doi.org/10.2478/acph-2019-0026
• Buyue, Y., Whinna, H. C., & Sheehan, J. P. (2008). The heparin-binding exosite of factor IXa is a critical regulator of plasma thrombin generation and venous thrombosis. Blood, 112(8), 3234–3241. https://doi.org/10.1182/blood-2008-01-136820
• Chen, X., Song, D., Nakada, S., Qiu, J., Iwamoto, K., Chen, R. H., Lim, Y. P., Jusko, W. J., & Stonestreet, B. S. (2020). Pharmacokinetics of inter-alpha inhibitor proteins and effects on hemostasis after hypoxic-ischemic brain injury in neonatal rats. Current Pharmaceutical Design, 26(32), 3997–4006. https://doi.org/10.2174/1381612826666200421123242
• Chng, W. S., Li, A. W. L., Lim, J. J. M., Leong, E. J. E., Amran, F. S., Kini, R. M., Chan, M. Y. Y., & Koh, C. Y. (2022). A factor xia inhibitor engineered from banded krait venom toxin: efficacy and safety in rodent models of arterial and venous thrombosis. Biomedicines, 10(7), 1679. https://doi.org/10.3390/biomedicines10071679
• Coleman, J. R., Moore, E. E., Silliman, C. C., Stettler, G. R., Nunns, G. R., Samuels, J. M., Bartley, M. G., Vigneshwar, N. G., Cohen, M. J., Fragoso, M., & Sauaia, A. (2020). Examining the effect of hypertonic saline administered for reduction of intracranial hypertension on coagulation. Journal of the American College of Surgeons, 230(3), 322–330.e2. https://doi.org/10.1016/j.jamcollsurg.2019.11.011
• Du, Z., Jia, H., Liu, J., Zhao, X., Wang, Y., & Sun, X. (2014). Protective effects of hydrogen-rich saline in uncontrolled hemorrhagic shock. Experimental and Therapeutic Medicine, 7(5), 1253–1258. https://doi.org/10.3892/etm.2014.1572
• Frattani, F. S., Coriolano, E. O., Lima, L. M., Barreiro, E. J., & Zingali, R. B. (2013). Oral antithrombotic effects of acylhydrazone derivatives. Journal of Atherosclerosis and Thrombosis, 20(3), 287–295. https://doi.org/10.5551/jat.14886
• Furugohri, T., Isobe, K., Honda, Y., Kamisato-Matsumoto, C., Sugiyama, N., Nagahara, T., Morishima, Y., & Shibano, T. (2008). DU-176b, a potent and orally active factor Xa inhibitor: in vitro and in vivo pharmacological profiles. Journal of Thrombosis and Haemostasis, 6(9), 1542–1549. https://doi.org/10.1111/j.1538-7836.2008.03064.x
• Garcia, J., Flood, V. H., Haberichter, S. L., Fahs, S. A., Mattson, J. G., Geurts, A. M., Zogg, M., Weiler, H., Shi, Q., & Montgomery, R. R. (2019). A rat model of severe VWD by elimination of the VWF gene using CRISPR/Cas9. Research and Practice in Thrombosis and Haemostasis, 4(1), 64–71. https://doi.org/10.1002/rth2.12280
• Gedar Totuk, Ö. M., Güzel, Ş. E., Ekici, H., Kumandaş, A., Emre Aydıngöz, S., Yılmaz, E. Ç., Kırdan, T., & Midi, A. (2020). Effects of algan hemostatic agent on bleeding time in a rat tail hemorrhage model. Turkish Journal of Trauma & Emergency Surgery, 26(6), 853–858. https://doi.org/10.14744/tjtes.2020.50384
• Ghrib, F., Léger, P., Ezban, M., Kristensen, A., Cambus, J., & Boneu, B. (2001). Anti-thrombotic and haemorrhagic effects of active site-inhibited factor VIIa in rats. British journal of haematology, 112(2), 506–512. https://doi.org/10.1046/j.1365-2141.2001.02570.x
• Greene, T. K., Schiviz, A., Hoellriegl, W., Poncz, M., Muchitsch, E. M., & Animal Models Subcommittee of the Scientific and Standardization Committee of the Isth (2010). Towards a standardization of the murine tail bleeding model. Journal of Thrombosis and Haemostasis, 8(12), 2820–2822. https://doi.org/10.1111/j.1538-7836.2010.04084.x
• Holly, S. P., Gera, N., Wang, P., Wilson, A., Guan, Z., Lin, L., Cooley, B., Alfar, H. R., Patil, R. G., Piatt, R., Leisner, T. M., Bergmeier, W., Majumder, R., & Parise, L. V. (2019). Ether lipid metabolism by AADACL1 regulates platelet function and thrombosis. Blood Advances, 3(22), 3818–3828. https://doi.org/10.1182/bloodadvances.2018030767
• Hoppensteadt, D. A., Gray, A., Jeske, W. P., Walenga, J. M., & Fareed, J. (2014). Anticoagulant and antithrombotic actions of AVE5026, an enriched anti-xa hemisynthetic ultra-low-molecular-weight heparin. Clinical and Applied Thrombosis/hHemostasis, 20(6), 621–628. https://doi.org/10.1177/1076029613480556
• Ito, Y., Noguchi, K., Morishima, Y., & Yamaguchi, K. (2018). Tissue-type plasminogen activator transgenic rats for evaluating inhibitors of the activated form of thrombin-activatable fibrinolysis inhibitor. Blood Coagulation & Fibrinolysis, 29(3), 314–321. https://doi.org/10.1097/MBC.0000000000000723
• Jeon, Y. D., Lee, J. H., Park, M. R., Lim, J. Y., Kang, S. H., Kim, D. K., & Lee, Y. M. (2021). Gastrodia elata blume and Zanthoxylum schinifolium siebold & zucc mixed extract suppress platelet aggregation and thrombosis. Medicina (Kaunas, Lithuania), 57(10), 1128. https://doi.org/10.3390/medicina57101128
• Jimenez-Martin, J., Las Heras, K., Etxabide, A., Uranga, J., de la Caba, K., Guerrero, P., Igartua, M., Santos-Vizcaino, E., & Hernandez, R. M. (2022). Green hemostatic sponge-like scaffold composed of soy protein and chitin for the treatment of epistaxis. Materials Today. Bio, 15, 100273. https://doi.org/10.1016/j.mtbio.2022.100273
• Johansen, P. B., Tranholm, M., Haaning, J., & Knudsen, T. (2016). Development of a tail vein transection bleeding model in fully anaesthetized haemophilia A mice - characterization of two novel FVIII molecules. Haemophilia, 22(4), 625–631. https://doi.org/10.1111/hae.12907
• Kuziej, J., Litinas, E., Hoppensteadt, D. A., Liu, D., Walenga, J. M., Fareed, J., & Jeske, W. (2010). In vivo neutralization of unfractionated heparin and low-molecular-weight heparin by a novel salicylamide derivative. Clinical and Applied Thrombosis/Hemostasis, 16(4), 377–386. https://doi.org/10.1177/1076029610366439
• Lauritzen, B., Tranholm, M., & Ezban, M. (2009). rFVIIa and a new enhanced rFVIIa-analogue, NN1731, reduce bleeding in clopidogrel-treated and in thrombocytopenic rats. Journal of Thrombosis and Haemostasis, 7(4), 651–657. https://doi.org/10.1111/j.1538-7836.2009.03287.x
• Lee, K. R., Chung, S. P., Park, I. C., & Kim, S. H. (2002). Effect of induced and spontaneous hypothermia on survival time of uncontrolled hemorrhagic shock rat model. Yonsei Medical Journal, 43(4), 511–517. https://doi.org/10.3349/ymj.2002.43.4.511
• Li, J. Y., Chang, T. C., Chang, N.C., Thanasekaran, J., & Chang, C. C. (2017). Anti-embolic effect of Taorenchengqi Tang in rats with embolic stroke induced by occluding middle cerebral artery. Journal of Traditional Chinese Medicine, 37(3), 326-332. https://doi.org/10.1016/S0254-6272(17)30068-7
• Lin, T. X., Lai, P. X., Mao, J. Y., Chu, H. W., Unnikrishnan, B., Anand, A., & Huang, C. C. (2019). Supramolecular aptamers on graphene oxide for efficient inhibition of thrombin activity. Frontiers in Chemistry, 7, 280. https://doi.org/10.3389/fchem.2019.00280
• Ma, R., Fu, W., Zhang, J., Hu, X., Yang, J., & Jiang, H. (2021). TMAO: a potential mediator of clopidogrel resistance. Scientific Reports, 11(1), 6580. https://doi.org/10.1038/s41598-021-85950-8
• Mashausi, D. S., Roy, D., Mangukiya, H. B., Merugu, S. B., Raza, G., Yunus, F. U., Liu, G. S., Negi, H., & Li, D. (2022). A high efficient FVIII variant corrects bleeding in hemophilia A mouse model. Biochemical and Biophysical Research Communications, 637, 358–364. https://doi.org/10.1016/j.bbrc.2022.02.066
• Meijers, J. C. M., Bakhtiari, K., Zwiers, A., & Peters, S. L. M. (2023). OKL-1111, A modified cyclodextrin as a potential universal reversal agent for anticoagulants. Thrombosis Research, 227, 17–24. https://doi.org/10.1016/j.thromres.2023.05.003
• Mohammed, B. M., Monroe, D. M., & Gailani, D. (2020). Mouse models of hemostasis. Platelets, 31(4), 417–422. https://doi.org/10.1080/09537104.2020.1719056
• Moore, E. E., Moore, H. B., Kornblith, L. Z., Neal, M. D., Hoffman, M., Mutch, N. J., Schöchl, H., Hunt, B. J., & Sauaia, A. (2021). Trauma-induced coagulopathy. Nature Reviews. Disease Primers, 7(1), 30. https://doi.org/10.1038/s41572-021-00264-3
• Morgan, C. E., Prakash, V. S., Vercammen, J. M., Pritts, T., & Kibbe, M. R. (2015). Development and validation of 4 different rat models of uncontrolled hemorrhage. JAMA surgery, 150(4), 316–324. https://doi.org/10.1001/jamasurg.2014.1685
• Naar, L., Dorken Gallastegi, A., Dowling, M., Mashbari, H. N. A., Wallace, B., Bankhead-Kendall, B., Beagle, J., Pallotta, J. B., Breen, K., Velmahos, G. C., Duggan, M. J., & King, C. D. R. (2022). Chitosan-based lifefoam improves survival in lethal noncompressible abdominal bleeding in swine. Surgery, 172(1), 421–426. https://doi.org/10.1016/j.surg.2022.01.016
• Nogawa, M., Watanabe, N., Koike, T., Fukuda, K., Ishiguro, M., Fujino, H., Hirayama, J., Shiba, M., Handa, M., Mori, T., Okamoto, S., Miyata, S., & Satake, M. (2022). Hemostatic function of cold-stored platelets in a thrombocytopenic rabbit bleeding model. Transfusion, 62(11), 2304–2313. https://doi.org/10.1111/trf.17128
• Oliveira, C., Valois, M. V., Ottaiano, T. F., Miranda, A., Hansen, D., Sampaio, M. U., Oliva, M. L. V., & de Abreu Maffei, F. H. (2021). The recombinant plant Bauhinia bauhinioides elastase inhibitor reduces rat thrombus without alterations in hemostatic parameters. Scientific Reports, 11(1), 13475. https://doi.org/10.1038/s41598-021-92745-4
• Peters, H., Wang, Y., Loof, T., Martini, S., Kron, S., Krämer, S., & Neumayer, H. H. (2004). Expression and activity of soluble guanylate cyclase in injury and repair of anti-thy1 glomerulonephritis. Kidney International, 66(6), 2224–2236. https://doi.org/10.1111/j.1523-1755.2004.66012.x
• Reck, J., Bandarra, P., Pavarini, S., Termignoni, C., Driemeier, D., Martins, J. R., & Guimarães, J. A. (2014). Experimentally induced tick toxicosis in rats bitten by Ornithodoros brasiliensis (Chelicerata: Argasidae): a clinico-pathological characterization. Toxicon, 88, 99–106. https://doi.org/10.1016/j.toxicon.2014.06.017
• Rodrigues, J. F. B., Queiroz, J. V. S. A., Medeiros, R. P., Santos, R. O., Fialho, D. A., Neto, J. E. S., Santos, R. L. D., Barbosa, R. C., Sousa, W. J. B., Torres, M. D. C. M., Medeiros, L. A. D. M., Silva, S. M. L., Montazerian, M., Fook, M. V. L., & Amoah, S. K. S. (2023). Chitosan-PEG gels loaded with Jatropha mollissima (Pohl) baill. ethanolic extract: an efficient and effective biomaterial in hemorrhage control. Pharmaceuticals (Basel, Switzerland), 16(10), 1399. https://doi.org/10.3390/ph16101399
• Rossato, P., Glantschnig, H., Leidenmühler, P., Kopic, A., Ruthsatz, T., Majer, B., Schuster, M., Scheiflinger, F., & Höllriegl, W. (2022). Absence of exaggerated pharmacology by recombinant ADAMTS13 in the rat and monkey. Blood Coagulation & Fibrinolysis, 33(1), 56–60. https://doi.org/10.1097/MBC.0000000000001064
• Saito, M. S., Lourenço, A. L., Kang, H. C., Rodrigues, C. R., Cabral, L. M., Castro, H. C., & Satlher, P. C. (2016). New approaches in tail-bleeding assay in mice: improving an important method for designing new anti-thrombotic agents. International Journal of Experimental Pathology, 97(3), 285–292. https://doi.org/10.1111/iep.12182
• Sener, D., Kocak, M., Saracoglu, R., Deveci, U., & Karadag, M. (2022). Histopathological effects of Algan hemostatic agent (AHA) in liver injury model in rats. Hepatology Forum, 3(1), 16–20. https://doi.org/10.14744/hf.2021.2021.0040
• Sener, D, Şanlı, Z. K., Abouhosa, A., Türet, D. M., & Seker, U. (2023). Hemostatic efficacy of algan hemostatic agent in renal vein incision model in rats. Journal of Harran University Medical Faculty, 20(1), 13-8. https://doi.org/10.35440/hutfd.1187636
• Sogut, O., Erdogan, M. O., Kose, R., Boleken, M. E., Kaya, H., Gokdemir, M. T., Ozgonul, A., Iynen, I., Albayrak, L., & Dokuzoglu, M. A. (2015). Hemostatic efficacy of a traditional medicinal plant extract (Ankaferd Blood Stopper) in bleeding control. Clinical and Applied Thrombosis/Hemostasis, 21(4), 348–353. https://doi.org/10.1177/1076029613504129
• Stagaard, R., Øvlisen, G. O., Klæbel, J. H., Danielsen, D., Lund, A., Elm, T., & Ley, C. D. (2023). In vivo effect of rFVIII and rFVIIa in hemophilia a rats evaluated by the tail vein transection bleeding model. Journal of Thrombosis and Haemostasis, 21(5), 1189–1199. https://doi.org/10.1016/j.jtha.2022.12.009
• Tiryaki, M., Demirel, Ö.U., Mohammadrezaloo, D.G., Gökçe, K., & Midi, A. (2025). Comparative efficacy of algan hemostatic agent powder and liquid forms in rat tail transection model: a controlled experimental study: algan hemostatic agent powder and liquid. Medical Science and Discovery, 12(1), 16-22. https://doi.org/10.36472/msd.v12i1.1242
• Toomey, J. R., Abboud, M. A., Valocik, R. E., Koster, P. F., Burns-Kurtis, C. L., Pillarisetti, K., Danoff, T. M., & Erhardt, J. A. (2006). A comparison of the beta-D-xyloside, odiparcil, to warfarin in a rat model of venous thrombosis. Journal of Thrombosis and Haemostasis, 4(9), 1989–1996. https://doi.org/10.1111/j.1538-7836.2006.02064.x
• Wu, S., Liang, C., Xie, X., Huang, H., Fu, J., Wang, C., Su, Z., Wang, Y., Qu, X., Li, J., & Liu, J. (2022). Hsp47 inhibitor Col003 attenuates collagen-induced platelet activation and cerebral ischemic-reperfusion injury in rats. Frontiers in Pharmacology, 12, 792263. https://doi.org/10.3389/fphar.2021.792263
• Zhang, X., Yang, Y., Wang, Y., Wu, J., Fang, Q., Wang, Y., Zhao, M., & Peng, S. (2022). (1R,3S)-THCCA-Asn: To show the discovery of selective inhibitor of thrombin by successfully combining virtual screening and biological assay. European Journal of Medicinal Chemistry, 242, 114681. https://doi.org/10.1016/j.ejmech.2022.114681
• Zintner, S. M., Small, J. C., Pavani, G., Dankner, L., Marcos- Contreras, O. A., Gimotty, P. A., Kjelgaard-Hansen, M., Wiinberg, B., & Margaritis, P. (2019). Gene-based FVIIa prophylaxis modulates the spontaneous bleeding phenotype of hemophilia A rats. Blood Advances, 3(3), 301–311. https://doi.org/10.1182/bloodadvances.2018027219